SVA — SINOVAC BIOTECH LTD
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1084201 ·
China
Last close
$6.47
Market Cap
$642.44M
52W High
$6.47
52W Low
$6.47
ADV30
0
Next earnings
—
No quarterly fundamentals indexed for this ticker.
Balance + Analyst (yfinance extras)
Retained Earnings
$2,815,942,000
Inventory
$94,309,000
Receivables
$313,087,000
ST Investments
$5,483,073,000
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
6
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| GERN | GERON CORP | $644.24M | $1.00 | — |
| BCAX | Bicara Therapeutics Inc. | $637.32M | $9.60 | — |
| OLMA | Olema Oncology, Inc. | $632.52M | $7.22 | — |
| DSGN | Design Therapeutics, Inc. | $630.12M | $9.84 | — |
| JANX | Janux Therapeutics, Inc. | $655.27M | $10.71 | — |
News headlines (Yahoo Finance, 1h cache)
SINOVAC Reports Unaudited First Half of 2026 Financial Results
2026-08-17 12:00 · Yahoo
SINOVAC Regained Compliance With the Nasdaq Global Market’s Listing Requirements
2026-06-15 10:00 · Yahoo
SINOVAC Reports Unaudited and Unreviewed Second Half of 2025 Financial Results and Files 2025 Annual Report on Form 20-F
2026-06-05 20:01 · Yahoo
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report
2026-05-29 20:01 · Yahoo
SINOVAC Announces Extension of Deadline to Submit Payment Instructions for Previously Declared Special Cash Dividend
2026-07-15 06:00 · Yahoo
OrbiMed Advisors Trims $125 Million Terns Stake After a Breakout Year, According to SEC Filing
2026-02-20 05:22 · Yahoo
Coxsackievirus Infections Market Research Report 2025-2035: High Burden of Pediatric and Neonatal Infections, Link to Type 1 Diabetes Risk, Advances in Vaccine Development Driving Expansion
2026-02-06 10:17 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.